Delta’s sneaky trick to evade the body’s immune response Griffith Health PublishedApril 20, 2022April 20, 2022 AuthorDeborah Marshall COVID-19's Delta strain may use a novel invasion method to cause more damage to the brain, intestine and kidneys.
Intranasal vaccine may deter antibiotic-resistant bacterium Centre for Cell Factories and Biopolymers PublishedApril 13, 2022April 13, 2022 AuthorDeborah Marshall Griffith University researchers have developed a potential vaccine for a pathogen causing severe infection in immunocompromised people.
Griffith University researchers lead human trials for malaria vaccine home PublishedMarch 23, 2022 AuthorDeborah Marshall The Institute for Glycomics’ malaria vaccine researchers are one step closer to human trials for a malaria vaccine that can be freeze-dried.
Studies reveal new mechanisms of arthritis caused by mosquito-borne viruses Griffith Health PublishedMarch 9, 2022March 10, 2022 AuthorDeborah Marshall Some successful rheumatoid arthritis therapies may help us better understand how to treat people with mosquito-borne viral diseases.
Red Cross sets up base at Griffith University following floods Griffith Sciences PublishedMarch 7, 2022 AuthorDeborah Marshall Australian Red Cross has temporarily established operational headquarters at Griffith University's Nathan campus.
Exercise trial aims to help women with recurrent ovarian cancer Griffith Health PublishedFebruary 24, 2022February 28, 2022 AuthorDeborah Marshall Griffith University researchers are conducting a world-leading trial assessing the role of exercise as therapy for women with recurrent ovarian cancer
Bacteria in the nose may increase risk of Alzheimer’s disease Griffith Institute for Drug Discovery (GRIDD) PublishedFebruary 18, 2022February 21, 2022 AuthorDeborah Marshall A bacterium commonly present in the nose can sneak into the brain and may increase the risk of Alzheimer’s disease.